Theranexus (XPAR:ALTHX) Beginning Cash Position : €4.74 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Theranexus Beginning Cash Position?

Theranexus's Beginning Cash Position for the quarter that ended in Dec. 2023 was €4.74 Mil.

Theranexus's quarterly Beginning Cash Position declined from Dec. 2022 (€11.52 Mil) to Jun. 2023 (€9.11 Mil) and declined from Jun. 2023 (€9.11 Mil) to Dec. 2023 (€4.74 Mil).

Theranexus's annual Beginning Cash Position increased from Dec. 2021 (€11.21 Mil) to Dec. 2022 (€12.53 Mil) but then declined from Dec. 2022 (€12.53 Mil) to Dec. 2023 (€9.11 Mil).

Theranexus Beginning Cash Position Historical Data

The historical data trend for Theranexus's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theranexus Beginning Cash Position Chart

Theranexus Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

15.17

9.45

11.21

12.53

9.11

Theranexus Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial												13.46	12.55	11.52	9.11	4.74

Theranexus Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Theranexus Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Theranexus's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Theranexus (XPAR:ALTHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

3VG:Germany

Address

60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008

Website

https://www.theranexus.com

Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus (XPAR:ALTHX) Headlines

No Headlines